Breastfeeding and Medications: what you need to know

Breastfeeding and medications: How much drug ends up in the child? Breastfeeding and taking medication at the same time is only acceptable if the active ingredient does not pass into the mother’s milk or the absorption is harmless for the infant. However, before a drug absorbed by the mother during the breastfeeding period has an … Breastfeeding and Medications: what you need to know

Zuclopenthixol

Products Zuclopenthixol is commercially available in the form of dragées, as drops, and as a solution for injection (Clopixol). It has been approved in many countries since 1977. Structure and properties Zuclopenthixol (C22H25ClN2OS, Mr = 400.7 g/mol) is present in drugs as zuclopenthixol dihydrochloride, zuclopenthixol acetate, or zuclopenthixol decanoate. Zuclopenthixol decanoate is a yellow, viscous, … Zuclopenthixol

Zonisamide

Products Zonisamide is commercially available in the form of capsules (Zonegran). It has been approved in many countries since 2006. Structure and properties Zonisamide (C8H8N2O3S, Mr = 212.2 g/mol) is a benzisoxazole derivative and a sulfonamide. It exists as a white powder that is soluble in water. Effects Zonisamide (ATC N03AX15) has anticonvulsant and antiepileptic … Zonisamide

Zopiclone

Products Zopiclone is commercially available in tablet form (Imovane, auto-generics). It has been approved in many countries since 1993. In the United States, the pure -enantiomer eszopiclone is also available (Lunesta). Structure and properties Zopiclone (C17H17ClN6O3, Mr = 388.8 g/mol) is a racemate and belongs to the cyclopyrrolones. It exists as a white to slightly … Zopiclone

Zofenopril

Products Zofenopril was approved in many countries in 2000 (Zofenil, Zofenil plus + hydrochlorothiazide). The drugs went off the market on April 23, 2011. Structure and properties Zofenopril (C22H23NO4S2, Mr = 429.6 g/mol) Effects Zofenopril (ATC C09AA15) has antihypertensive properties and relieves cardiac stress. Indications Hypertension Acute myocardial infarction

Zoledronic Acid

Products Zoledronic acid is commercially available as an infusion preparation (Zometa, Aclasta, generics). It has been approved in many countries since 2000. Structure and properties Zoledronic acid (C5H10N2O7P2, Mr = 272.1 g/mol) is present in drugs as zoledronic acid monohydrate, a white crystalline powder that is sparingly soluble in water. It is an imidazole derivative … Zoledronic Acid

Zolmitriptan

Products Zolmitriptan is commercially available as film-coated tablets, meltable tablets, and as a nasal spray (Zomig, generics). It has been approved in many countries since 1997. Generic versions entered the market in 2012. Structure and properties Zolmitriptan (C16H21N3O2, Mr = 287.4 g/mol) is an indole and oxazolidinone derivative structurally related to serotonin. It exists as … Zolmitriptan